Benign bone-forming tumors [Gutartige knochenbildende tumoren]

被引:0
|
作者
Heuck A. [1 ]
Stäbler A. [2 ]
Wörtler K. [3 ]
Steinborn M. [2 ]
机构
[1] Institut für Klinische Radiologie, Klinikum Großhadern, Universität München
[2] Institut für Röntgendiagnostik, Klinikum rechts der Isar, Technische Universität München
来源
Der Radiologe | 2001年 / 41卷 / 7期
关键词
Bone neoplasms; CT; MR; Osteoblastoma; Osteoid osteoma; Osteoma; Radiographs; Therapy;
D O I
10.1007/s001170170144
中图分类号
学科分类号
摘要
Benign bone-forming tumors include osteomas, enostomas, osteoid osteomas, and osteoblastomas. These lesions are often characterized by typical imaging findings on radiographs, CT and MR imaging studies. Radiologic findings and additional clinical information allow for a specific diagnosis in most cases. This review article emphasizes the radiological patterns of benign bone-forming tumors as well as their epidemiological, clinical, and pathological characteristics. In addition, minimally invasive interventional procedures for the therapy of osteoid osteoma are reviewed.
引用
收藏
页码:540 / 547
页数:7
相关论文
共 50 条
  • [21] A benign bone-forming tumour ( osteoma) on the skull of a fossil balaenopterid whale from the Pliocene of Chile
    Hampe, Oliver
    Witzmann, Florian
    Asbach, Patrick
    ALCHERINGA, 2014, 38 (02): : 266 - 272
  • [22] NEW PERSPECTIVES IN THE DIFFERENTIATION OF BONE-FORMING CELLS
    SCUTT, A
    MAYER, H
    WINGENDER, E
    BIOFACTORS, 1992, 4 (01) : 1 - 13
  • [23] RNAi-screening in bone-forming cells
    Kroll T.
    Ahmad M.
    Ploubidou A.
    Tuckermann J.
    BIOspektrum, 2019, 25 (5) : 523 - 526
  • [24] Role of bone-forming agents in the management of osteoporosis
    McClung, Michael R.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (04) : 775 - 791
  • [25] Bone-forming properties of an ascorbic acid derivative
    Phillips, Robert
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (07) : 397 - 397
  • [26] Treatment of Osteoporosis: Role of Bone-Forming Agents
    J.-Y. Reginster
    V. Halkin
    Y. Henrotin
    C. Gosset
    Osteoporosis International, 1999, 9 (Suppl 2) : S91 - S96
  • [27] Role of bone-forming agents in the management of osteoporosis
    Michael R. McClung
    Aging Clinical and Experimental Research, 2021, 33 : 775 - 791
  • [28] WHEN AND WHY USE A BONE-FORMING AGENT?
    McCloskey, E.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S157 - S157
  • [29] Bone-forming lesions and rearrangements of FOS genes
    Krantschenko, Emma
    Khayat, Paul
    Siegfried, Aurore
    Van Acker, Nathalie
    Gomez-Brouchet, Anne
    ANNALES DE PATHOLOGIE, 2022, 42 (03) : 208 - 213
  • [30] Challenges for the Development of Bone-Forming Agents in Europe
    John A. Kanis
    Rene Rizzoli
    Cyrus Cooper
    Jean-Yves Reginster
    Calcified Tissue International, 2014, 94 : 469 - 473